Matthias Müller

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

Ilona Steigerwald, Matthias Müller, Anthony Davies et al. · Current Medical Research and Opinion · 2012 · 82 citations

Effectiveness of Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study

Ralf Baron, Rudolf Likar, E. Martín‐Mola et al. · Pain Practice · 2015 · 68 citations · Full text

Effectiveness and Safety of Tapentadol Prolonged Release (<scp>PR</scp>) Versus a Combination of Tapentadol <scp>PR</scp> and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

Ralf Baron, E. Martín‐Mola, Matthias Müller et al. · Pain Practice · 2014 · 68 citations · Full text

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial

Ralf Baron, Jan‐Peter Jansen, Andreas Binder et al. · Pain Practice · 2015 · 67 citations · Full text

Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee – study protocol for a randomized controlled trial

Claudia M. Witt, Andreas Michalsen, Stephanie Roll et al. · Trials · 2013 · 63 citations · Full text